COMPASS Pathways is a mental health care company founded in 2016 to
accelerate patient access to evidence-based innovation in mental health.
Our first major initiative is developing psilocybin therapy through
late-stage clinical trials in the EU and US for patients with
treatment-resistant depression. We want to improve mental health and
well-being through the development of new patient care pathways, based on
advances in neuroscience, psychotherapy, psychopharmacology and digital